Group 1 - Huaying Medical, a company with core component autonomy in ultrasound technology, has completed a new round of financing led by Nanshan Venture Capital, with participation from existing shareholder Shanghai Ke Investment [1] - Founded in 2020 and incubated by the Shenzhen Institute of Advanced Technology, Huaying Medical specializes in ultrasound transducer technology, active interventional catheter technology, and high-frequency ultrasound imaging systems, making it one of the few companies capable of mastering the entire ultrasound technology chain [1][2] - The company has a strong technical foundation backed by the Chinese Academy of Sciences and has undertaken significant ultrasound-related projects, showcasing deep technical reserves in innovative applications such as ultrasound catheter imaging and ultrasound therapy [2] Group 2 - The rise of precision treatment is driving rapid development in intracardiac imaging (ICE), with Huaying Medical positioned to leverage its full-chain autonomous technology for transducer localization, achieving cost reduction while maintaining stability [3] - Huaying Medical has completed product development for 4D-ICE, which enhances visualization in structural heart procedures, and possesses comprehensive core technologies for 4D-ICE, including imaging probes and algorithms [3] - The company is expanding its applications in ultrasound beyond imaging, breaking import monopolies with several exclusive domestic products in areas such as ultrasound liquid handling and high-frequency imaging devices [4] Group 3 - Investors express confidence in Huaying Medical's ability to address domestic procurement challenges and provide high-quality imaging solutions, particularly in the context of 4D-ICE technology [5] - The company has established a national high-tech platform for high-frequency medical ultrasound technology, with significant funding aimed at developing advanced ultrasound products [6] - Nanshan Venture Capital and Shanghai Ke Investment highlight the company's strong technical foundation and diverse product pipeline, positioning it as a potential industry leader in ultrasound technology [7][8]
欢影医疗完成新一轮融资
Sou Hu Cai Jing·2025-05-12 00:21